Search Within

Vincent Miller

Formats
  1. Journal Article (152)
  2. Meeting Abstract (114)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (207)
  2. Solid Tumor Oncology Division (197)
  3. Thoracic Oncology (189)
  4. Department of Pathology and Laboratory Medicine (71)
  5. GSK Faculty (67)
  6. Human Oncology and Pathogenesis Program (64)

More Groups

People
  1. Mark Kris (172)
  2. Gregory Riely (79)
  3. William Pao (65)
  4. Marc Ladanyi (59)
  5. Christopher Azzoli (46)
  6. Maureen Zakowski (46)

More People

Years
  1. 2019 (1)
  2. 2017 (2)
  3. 2016 (1)
  4. 2015 (3)
  5. 2014 (5)
  6. 2013 (4)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Clinical Cancer Research (39)
  3. Journal of Thoracic Oncology (24)
  4. Seminars in Oncology (13)
  5. Cancer (10)
  6. Cancer Chemotherapy and Pharmacology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (57)
  3. Elsevier Inc. (38)
  4. Elsevier Science, Inc. (11)
  5. Springer (10)
  6. Wiley Blackwell (10)

More Publishers

Results (270)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinomas and correlation with EGFR and KRAS mutation status and EGFR immunohistochemistry reactivity
    Meeting Abstract

    Varella, G. M.; Ladanyi, M.; Kris, M. G.; Rekhtman, N.; Hirsch, F.; Miller, V.; Riely, G.; Pao, W.; Zakowski, M. F.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification
    Meeting Abstract

    Travis, W. D.; Brambilla, E.; Noguchi, M.; Geisinger, K.; Beer, D.; Powell, C. A.; Johnson, B.; Riely, G. J.; Rusch, V.; Asamura, H.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Rebiopsy of patients with "acquired resistance" to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Miller, V. A.; Riely, G. J.; Arcila, M. E.; Oxnard, G.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Ladanyi, M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)
    Meeting Abstract

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Biomarker evaluation in the randomized, double-blind, placebo-controlled, Phase IIIb ATLAS Trial, comparing bevacizumab (B) therapy with or without erlotinib (E), after completion of chemotherapy with B for the treatment of locally-advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Johnson, B.; Miller, V.; Amler, L.; Stern, H.; Soh, C.; O'connor, P.; Kabbinavar, F.
    EJC Supplements (2009)

    Fulltext@MSK | Save
  • Impact of EGFR and KRAS mutations on clinical outcomes in previously untreated patients with advanced NSCLC treated with gefitinib or erlotinib: Results of an online tumor registry of clinical trials
    Meeting Abstract

    Jackman, D. M.; Miller, V. A.; Cioffredi, L. A.; Yeap, B. Y.; Jänne, P. A.; Riely, G. J.; Ruiz, M. G.; Giaccone, G.; Sequist, L. V.; Johnson, B. E.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • EGFR Exon 19 insertions in lung adenocarcinoma
    Meeting Abstract

    He, M.; Nafa, K.; Arcila, M.; Brevet, M.; Oxnard, G.; Miller, V.; Ladanyi, M.
    Journal of Molecular Diagnostics (2009)

    Fulltext@MSK | Save
  • Improved detection of the EGFR T790M mutation in lung cancer patients with acquired resistance to EGFR TKIs using a locked nucleic acid-based approach
    Meeting Abstract

    Arcila, M. E.; Nafa, K.; Oxnard, G.; Miller, V.; Ladanyi, M.
    Journal of Molecular Diagnostics (2009)

    Fulltext@MSK | Save
  • Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib
    Journal Article

    Zakowski, M. F.; Hussain, S.; Pao, W.; Ladanyi, M.; Ginsberg, M. S.; Heelan, R.; Miller, V. A.; Rusch, V. W.; Kris, M. G.
    Archives of Pathology & Laboratory Medicine (2009)

    Fulltext@MSK | Save